References
Calvert AH, Harland SJ, Newell DR, Siddik ZH, Jones AC, McElwain T, Raju S, Wiltshaw E, Smith IE, Baker JM, Peckham MJ, Harrap KR (1982) Early clinical studies with cis-diammine-1,1-cyclobutane dicarboxylate platinum II. Cancer Chemother Pharmacol 9:140–147
Canetta R, Rozencweig M, Carter SK (1985) Carboplatin: the clinical spectrum to date. Cancer Treat Rev 12 (Suppl A): 125–136
Elferink, F, Van der Vijgh WJF, Pinedo HM (1986) On-line differential pulse polarographic detection of carboplatin in biological samples after chromatographic separation. Anal Chem 58:2293–2296
Elferink F, Van der Vijgh WJF, Klein I, Vermorken JB, Gall HE, Pinedo HM (1987) Pharmacokinetics of diammine-(1,1-cyclobutanedicarboxylate)-platinum II (carboplatin) after intravenous administration. Cancer Treat Rep 71:1231–1237
Siddik ZH, Boxal FE, Goddard PM, Barnard CFJ, Harrap KR (1984) Antitumour, pharmacokinetic, and toxicity studies with orally administered cisplatin, CBDCA and CHIP. Proc Am Assoc Cancer Res Abstract 1462
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Hennik, M.B., van der Vijgh, W.J.F., Klein, I. et al. Human pharmacokinetics of carboplatin after oral administration. Cancer Chemother. Pharmacol. 23, 126–127 (1989). https://doi.org/10.1007/BF00273533
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00273533